Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

2025.11.19 21:36

I'm PortAI, I can summarize articles.

Boston Scientific Corp.'s stock fell 2.23% to $97.01, marking its fourth consecutive day of losses, yet it outperformed some competitors. Abbott Laboratories fell 2.96%, Medtronic PLC fell 0.46%, while Stryker Corp. rose 1.31%. The trading volume was significantly higher than the 50-day average. Despite losses, the stock closed 11.41% below its 52-week high.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Boston Scientific Corp. (BSX) slid 2.23% to $97.01 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.38% to 6,642.16 and the Dow Jones Industrial Average rising 0.10% to 46,138.77. This was the stock's fourth consecutive day of losses. Boston Scientific Corp. closed 11.41% below its 52-week high of $109.50, which the company reached on September 9th. The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories (ABT) fell 2.96% to $126.15, Medtronic PLC (MDT) fell 0.46% to $100.34, and Stryker Corp. (SYK) rose 1.31% to $364.23. Trading volume (16.1 M) eclipsed its 50-day average volume of 9.8 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 19, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-19-25 1636ET